Federal contract

Johnson & Johnson (JNJ): VA awarded $21K

VA awarded Johnson & Johnson a contract with $21K committed so far.

$21K
committed so far
Signed
May 28, 2026
Updated
Jun 2, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Dec 16, 2025Federal contractDepartment of Veterans Affairs awarded Johnson & Johnson: $0 obligated to date
  2. Feb 19, 2026Federal contract · $155K obligatedDepartment of Defense awarded Johnson & Johnson: $155K obligated to date
  3. Feb 23, 2026Federal contract · $371K obligatedDepartment of Defense awarded Johnson & Johnson: $371K obligated to date
  4. Feb 26, 2026Federal contract · $272K obligatedDepartment of Defense awarded Johnson & Johnson: $272K obligated to date
  5. Mar 4, 2026Federal contract · $205K obligatedDepartment of Defense awarded Johnson & Johnson: $205K obligated to date
  6. Mar 10, 2026CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  7. Mar 16, 2026Federal contract · $205K obligatedDepartment of Defense awarded Johnson & Johnson: $205K obligated to date
  8. Mar 19, 2026Congress · 2 peopleMembers of Congress: 3 sales
  9. Mar 26, 2026CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
  10. Mar 27, 2026CongressDisclosed purchase of JNJ — reported range $15,001 - $50,000
  11. Mar 30, 2026CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  12. Apr 10, 2026Federal contract · $198K obligatedDepartment of Defense awarded Johnson & Johnson: $198K obligated to date
  13. Apr 14, 2026Company filing · Form 8-K · Results, Other newsReported its results, and reported other company news
  14. May 1, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
  15. May 28, 2026 · this disclosureFederal contract · $21K obligatedDepartment of Veterans Affairs awarded Johnson & Johnson: $21K obligated to date

What came next

  1. Jun 2, 2026CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
  2. Jun 9, 2026CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  3. Jun 11, 2026Insider · First sale since 2023Officer sold ~$2.41M of JNJ shares in the open market
  4. Jun 25, 2026FDAFDA device clearance: Coated VICRYL™ (Polyglactin 910) Plus Antibacterial Suture
  5. Jun 25, 2026FDAFDA device clearance: ATTUNE Total Knee System; ATTUNE Cementless Knee System
  6. Jun 25, 2026FDAFDA device clearance: VELYS™ Robotic-Assisted Solution
  7. Jun 29, 2026CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
  8. Jul 7, 2026Federal contract · $168K obligatedDepartment of Defense awarded Johnson & Johnson: $168K obligated to date
  9. Jul 15, 2026Company filing · Form 8-K · ResultsReported its results
  10. Jul 20, 2026InsiderOfficer sold ~$5.79M of JNJ shares in the open market
  11. Jul 23, 2026FDARecall: Velys Enabling Tech Robotic-Assist Station REF: 451611001
  12. Jul 23, 2026Federal contract · $182K obligatedDepartment of Defense awarded Johnson & Johnson: $182K obligated to date
  13. Jul 25, 2026FDAFDA device clearance: MONARCH™ Platform (MON-000008)
  14. Jul 27, 2026FDAFDA device clearance: Shockwave Intravascular Lithotripsy (IVL) System with the Shockwave E8 Peripheral IVL Catheter
  15. Jul 30, 2026Federal contract · $385K obligatedDepartment of Veterans Affairs awarded Johnson & Johnson: $385K obligated to date
  16. Jul 30, 2026CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
  17. Jul 31, 2026FDARecall: HEALON EndoCoat PRO, REF: 10300012 (US/CAN) HEALON DUET PRO II, REF: 10300016 (US/CAN) HEALON EndoCoat PRO, REF: 10301012 (EU); HEALON DUET PRO II, REF: 103010…
  18. Jul 31, 2026Federal contract · $21K obligatedDepartment of Veterans Affairs awarded Johnson & Johnson: $21K obligated to date
  19. Aug 4, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On August 4, 2026, the Company announced that Jennifer Taubert will retire from her position as Executive Vice President, Worldwide Chairman, Innovative Medicine and member of the Executive Committee effective September 1, 2026.”
  20. Aug 5, 2026Insider · 1 personInsiders: 2 sales (~$12.5M)
View the official recordUSAspending.gov award record

How to read USAspending.gov award record

The obligated amount is money the government has legally committed to pay and has set aside in its accounts. The ceiling, which USAspending calls the potential value, is the most the contract could be worth if every option is exercised and every possible order is placed. The ceiling is a limit, not a payment, and it is often many times the obligated amount.

Full guide: Contract ceiling vs obligated amount: the difference

What else is on file for Johnson & Johnson

For Johnson & Johnson, OQRO holds 14 insider filings (SEC Form 4 or Form 144), 4 Congress trade reports, 119 fund holdings reports (13F) and 6 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its JNJ page.

How this filing works

Explore the data

Other disclosures at Johnson & Johnson

Everything OQRO holds on this company is on its JNJ page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data